Compugen (CGEN)

Compugen Ltd

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CGEN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next >>

Date	Time	Source	Headline	Symbol	Company
12/02/2020	20:26	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CGEN	Compugen Ltd
12/02/2020	11:16	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CGEN	Compugen Ltd
09/01/2020	12:10	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
12/12/2019	16:35	GlobeNewswire Inc.	Janpix, Inc. Announces Appointment of Sanford (Sandy) Zweifach as Executive Chairman to its Board of Directors	NASDAQ:CGEN	Compugen Ltd
12/11/2019	12:09	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
05/11/2019	13:08	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
04/11/2019	12:15	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
19/09/2019	13:46	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
09/09/2019	11:16	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CGEN	Compugen Ltd
06/09/2019	19:12	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CGEN	Compugen Ltd
13/08/2019	11:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CGEN	Compugen Ltd
05/08/2019	12:33	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:CGEN	Compugen Ltd
05/08/2019	12:02	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
02/07/2019	12:00	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
03/06/2019	12:00	PR Newswire (US)	Compugen Presents Update on COM701 Phase 1 Trial at the 2019 ASCO Annual Meeting	NASDAQ:CGEN	Compugen Ltd
30/05/2019	15:19	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:CGEN	Compugen Ltd
22/05/2019	12:00	PR Newswire (US)	Compugen to Present at the Jefferies 2019 Healthcare Conference	NASDAQ:CGEN	Compugen Ltd
20/05/2019	12:05	PR Newswire (US)	Compugen Reports First Quarter 2019 Results	NASDAQ:CGEN	Compugen Ltd
20/05/2019	12:01	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
20/05/2019	12:00	PR Newswire (US)	Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With Advanced Solid ...	NASDAQ:CGEN	Compugen Ltd
06/05/2019	12:00	PR Newswire (US)	Compugen First Quarter 2019 Conference Call Scheduled for Monday, May 20, 2019 at 8:30 AM ET	NASDAQ:CGEN	Compugen Ltd
03/04/2019	12:00	PR Newswire (US)	Compugen Presents Update on COM701 Phase 1 Trial at the 2019 AACR Annual Meeting	NASDAQ:CGEN	Compugen Ltd
26/03/2019	12:40	PR Newswire (US)	Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed's Oral Insulin Capsules	NASDAQ:CGEN	Compugen Ltd
26/03/2019	11:00	PR Newswire (US)	Compugen Announces Purchase of Company Shares by its Board of Directors and Members of Management	NASDAQ:CGEN	Compugen Ltd
21/03/2019	10:43	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:CGEN	Compugen Ltd
12/03/2019	11:46	PR Newswire (US)	Compugen Announces Issuance of Two U.S. Composition of Matter Patents for COM701, Its Lead Immuno-Oncology Product Candidate	NASDAQ:CGEN	Compugen Ltd
05/03/2019	12:00	PR Newswire (US)	Compugen to Present at the Cowen and Company 39th Annual Health Care Conference	NASDAQ:CGEN	Compugen Ltd
01/03/2019	12:00	PR Newswire (US)	Compugen Presents Update on COM701 Phase 1 Trial at ASCO-SITC Clinical Immuno-Oncology Symposium	NASDAQ:CGEN	Compugen Ltd
26/02/2019	11:07	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
26/02/2019	07:00	PR Newswire (US)	Compugen Reports Fourth Quarter and Full Year 2018 Results and Announces Corporate Restructuring to Streamline Operations	NASDAQ:CGEN	Compugen Ltd